Tag: Yale

All

RA Drug May Help Treat Recalcitrant Eczema

Treatment with the janus kinase (JAK) inhibitor XELJANZ® (tofacitinib citrate) led to dramatic improvement in six patients with moderate to severe eczema who had previously failed conventional therapies.

NF1 Identified as “Major Player” in Melanoma
Newly Developed Sunblock Won’t Penetrate the Skin

All

Sorry, No Posts Found

All

FDA Clears Expanded Indications for Swift Microwave Wart Device

New data show the Swift system reduces blistering, discomfort, and recovery time while maintaining strong clinical outcomes for common and plantar warts.

Regenerative and Personalized Care Lead 2026 Facial Plastic Surgery Trends
Allergan Aesthetics to Present Phase 3 Data for First-in-Class Botulinum Neurotoxin E
FDA Warns Websites Over Unapproved Botox Products

Tag: Yale

All

RA Drug May Help Treat Recalcitrant Eczema

NF1 Identified as “Major Player” in Melanoma

Newly Developed Sunblock Won’t Penetrate the Skin

All

Sorry, No Posts Found

All

FDA Clears Expanded Indications for Swift Microwave Wart Device

Regenerative and Personalized Care Lead 2026 Facial Plastic Surgery Trends

Allergan Aesthetics to Present Phase 3 Data for First-in-Class Botulinum Neurotoxin E

FDA Warns Websites Over Unapproved Botox Products

Sorry, No Posts Found

Plastic Surgery Practice

Our Parent Company

Key Resources

Helpful Links